Press "Enter" to skip to content

FDA Expands Eligibility Criteria of Booster Shots to 16 and 17 Year Age Adults

Today the US FDA has amended the emergency use of authorization for Pfizer’s Covid-19 vaccine to administer to 16 and 17 age individuals. The booster does for 17 and 16 age individuals will be given only if they have completed at least six months of primary vaccination with Pfizer’s COVID-19 Vaccine.

The US Centers of Disease Control and Prevention board said that it is strengthening its covid-19n vaccine recommendations and advising people to take booster shot of Pfizer-BioNTech. CDC Director Rochelle Walensky said that there is no full proof data on Omicron variant but according to the initial data released by certain agencies suggest that the booster shoots will be helpful in strengthening the immunity and protecting against the Omicron and other variant.

The announcement came just after FDA authorized the booster shots of Pfizer-BioNTech for 16 and 17 years age individuals.The Director of CDC said that the booster shots of covid-19 vaccine are effective enough and safe and the adolescents aged 16 and 17 can take the booster shots at least completion of six months of primary Pfizer vaccination. In US nearly 4.7 million adolescents aged 16 to 17 age are fully vaccinated including about 2.5 million teenagers who have completed at least six months of the initial vaccination series.

The authorization move and the recommendations by FDA come as the US officials are worried about the new Omicron variant that was first found in Africa and later being identifying cases in many countries across the world. There is no advanced data about the new variant on how dangerous or how effective the current vaccines are but the initial data shows that the current vaccinations can protect people and can strengthen their immunity.

Be First to Comment

Leave a Reply

Your email address will not be published. Required fields are marked *